We have previously shown that fewer than five unique tumor HLA class I alleles combined with low TMB was associated with lower CD8+ T cell infiltration and was predictive of worse overall survival in this NSCLC cohort, suggesting HLA loss is an adaptive mechanism for immune evasion in tumors with high mutation burden (25). The gene discussed is CD8A; the disease is non-small cell lung carcinoma.